HOME › DRUGS › MARSTACIMAB
ACTIVE SUBSTANCE / INN

MARSTACIMAB

Brand name(s): Hympavzi
EMA LISTED
AUTHORISED
Hemophilia A;Hemophilia B
ACTIVE SUBSTANCE
Marstacimab
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
HympavziPfizer Europe MA EEIGAuthorised18/11/2024Hemophilia A;Hemophilia B

FULL INTELLIGENCE ON MARSTACIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →